New hope for tough T-Cell cancers: immunotherapy after transplant shows promise
NCT ID NCT04972942
First seen Apr 24, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This early-phase trial tests whether adding the immunotherapy drug daratumumab after a stem cell transplant is safe for children, teens, and young adults with high-risk T-cell acute lymphoblastic leukemia or lymphoma. About 30 participants will receive the drug after standard transplant conditioning. The goal is to see if it helps prevent the cancer from coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Children's Hospital Colordao
NOT_YET_RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Children's National Medical Center
NOT_YET_RECRUITINGWashington D.C., District of Columbia, 20010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Helen DeVos Children's Hospital
RECRUITINGGrand Rapids, Michigan, 49503, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
John Hopkins All Children's Hospital
NOT_YET_RECRUITINGSt. Petersburg, Florida, 33701, United States
-
Loma Linda University Children's Hospital
RECRUITINGLoma Linda, California, 92354, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MD Anderson Cancer Center
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
-
Medical College of Wisconsin
NOT_YET_RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Nationwide Children's Hosptial
NOT_YET_RECRUITINGColumbus, Ohio, 43205, United States
-
New York Medical College
RECRUITINGVallhala, New York, 10595, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Phoenix Children's Hospital
NOT_YET_RECRUITINGPhoeniz, Arizona, 85016, United States
-
Riley Children's Hospital
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California
RECRUITINGSan Francisco, California, 94143, United States
-
University of Florida
RECRUITINGGainsville, Florida, 32608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.